Price & volume screen · refreshed after the Sep 28, 2026 close
Most volatile stocks: Healthcare
Companies with the widest daily price swings over the last 60 sessions. Annualised standard deviation of daily returns over 60 sessions. Higher volatility means bigger moves in both directions.
| # | Company | Price | Today | Volatility 60d | 1M | Mkt cap |
|---|---|---|---|---|---|---|
| 1 | MPLTMapLight TherapeuticsHealthcare | $10.45 | −0.10% | 279.4% | −16.7% | $580.8M |
| 2 | CAPRCapricor TherapeuticsHealthcare | $8.71 | +4.19% | 265.7% | −13.4% | $506.4M |
| 3 | MRNAModernaHealthcare | $197.28 | −0.80% | 227.6% | +38.2% | $78.76B |
| 4 | BIOABioAge LabsHealthcare | $7.18 | +1.84% | 217.5% | −28.8% | $329.5M |
| 5 | KODKodiak SciencesHealthcare | $89.92 | +177.96% | 214.8% | +129.9% | $5.65B |
| 6 | REPLReplimune GroupHealthcare | $12.56 | +1.62% | 192.1% | −19.5% | $1.18B |
| 7 | INDPIndaptus TherapeuticsHealthcare | $3.29 | −14.55% | 191.9% | +183.6% | $438.4M |
| 8 | ALMSAlumisHealthcare | $7.16 | +0.85% | 182.4% | −69.2% | $926.8M |
| 9 | SRZNSurrozenHealthcare | $29.64 | +0.34% | 166.3% | +23.4% | $348.4M |
| 10 | AGENAgenusHealthcare | $9.43 | +10.42% | 153.6% | +20.7% | $425.9M |
| 11 | CYPHCypherpunk TechnologiesHealthcare | $3.31 | −19.66% | 153.4% | +75.1% | $356.7M |
| 12 | ENTXEntera BioHealthcare | $2.69 | −2.00% | 149.2% | −12.7% | $465.8M |
| 13 | MYGNMyriad GeneticsHealthcare | $4.24 | +1.68% | 140.5% | +33.3% | $405.6M |
| 14 | RCELAvita MedicalHealthcare | $11.67 | −1.44% | 127.6% | +13.1% | $360.9M |
| 15 | RAREUltragenyx PharmaceuticalHealthcare | $14.41 | −0.62% | 127.0% | −45.1% | $1.42B |
| 16 | AMLXAmylyx PharmaceuticalsHealthcare | $29.85 | +1.22% | 116.4% | −19.7% | $3.81B |
| 17 | BLLNBillionToOneHealthcare | $121.72 | −1.10% | 115.2% | +27.9% | $5.74B |
| 18 | AHCOAdaptHealthHealthcare | $5.65 | +0.18% | 111.0% | −2.6% | $753.8M |
| 19 | IOVAIovance BiotherapeuticsHealthcare | $10.99 | −0.09% | 107.7% | +33.1% | $4.98B |
| 20 | TTRXTurn TherapeuticsHealthcare | $13.04 | +4.40% | 105.0% | +29.0% | $396.0M |
| 21 | COHRCoherentHealthcare | $282.45 | −4.52% | 99.5% | −4.4% | $55.31B |
| 22 | ABCLAbCellera BiologicsHealthcare | $13.92 | +9.61% | 98.9% | +12.3% | $4.51B |
| 23 | ARCTArcturus Therapeutics HoldingsHealthcare | $14.46 | +4.40% | 98.1% | −10.6% | $411.0M |
| 24 | DNAGinkgo Bioworks HoldingsHealthcare | $10.46 | −1.88% | 97.1% | +44.1% | $704.4M |
| 25 | RGNXREGENXBIOHealthcare | $7.47 | +0.95% | 94.9% | −20.3% | $493.1M |
| 26 | BFLYButterfly NetworkHealthcare | $9.15 | −2.56% | 94.7% | +4.9% | $2.44B |
| 27 | GRALGRAILHealthcare | $132.63 | +4.52% | 93.0% | +60.8% | $5.92B |
| 28 | ETONEton PharmaceutcialsHealthcare | $59.18 | +2.60% | 92.3% | −5.6% | $1.69B |
| 29 | IRDOpus GeneticsHealthcare | $5.05 | +6.09% | 90.5% | +31.2% | $420.1M |
| 30 | SLSSELLAS Life Sciences GroupHealthcare | $11.59 | −0.17% | 90.5% | −23.8% | $2.34B |
| 31 | TWSTTwist BioscienceHealthcare | $179.60 | −1.77% | 89.9% | +17.3% | $11.91B |
| 32 | EBSEmergent BiosolutionsHealthcare | $6.86 | +1.03% | 89.4% | +15.5% | $351.7M |
| 33 | BBOTBridgeBio Oncology TherapeuticsHealthcare | $3.81 | −3.54% | 89.2% | −58.5% | $305.5M |
| 34 | AGLagilon healthHealthcare | $79.53 | −1.49% | 87.8% | −15.6% | $1.34B |
| 35 | TYRATyra BiosciencesHealthcare | $21.45 | −1.42% | 87.5% | −17.9% | $1.47B |
| 36 | GALTGalectin TherapeuticsHealthcare | $3.93 | +0.77% | 85.9% | −5.1% | $396.3M |
| 37 | HIMSHims & Hers HealthHealthcare | $28.78 | −2.18% | 84.8% | −9.1% | $6.71B |
| 38 | PRMEPrime MedicineHealthcare | $2.88 | −0.86% | 84.8% | −21.0% | $521.5M |
| 39 | PRLDPrelude Therapeutics IncorporatedHealthcare | $3.91 | +0.90% | 84.2% | −38.3% | $312.0M |
| 40 | EIKNEikon TherapeuticsHealthcare | $7.91 | −0.13% | 83.9% | −31.3% | $428.4M |
| 41 | XENEXenon PharmaceuticalsHealthcare | $36.72 | −0.60% | 83.8% | −40.7% | $3.56B |
| 42 | VKTXViking TherapeuticsHealthcare | $33.03 | −7.11% | 83.5% | −2.5% | $4.11B |
| 43 | CDNACareDxHealthcare | $64.60 | +1.44% | 82.5% | +23.4% | $3.34B |
| 44 | QDELQuidelOrthoHealthcare | $10.83 | −1.01% | 82.3% | −29.3% | $742.7M |
| 45 | GLUEMonte Rosa TherapeuticsHealthcare | $11.71 | −0.51% | 82.0% | −18.2% | $999.0M |
| 46 | IMMXImmix BiopharmaHealthcare | $11.47 | +4.56% | 81.9% | −19.8% | $820.6M |
| 47 | ALNYAlnylam PharmaceuticalsHealthcare | $255.36 | −0.23% | 81.5% | +7.9% | $34.17B |
| 48 | OMEROmerosHealthcare | $19.43 | −3.24% | 81.3% | +0.9% | $1.41B |
| 49 | PHATPhathom PharmaceuticalsHealthcare | $7.35 | +0.68% | 81.1% | −17.8% | $594.6M |
| 50 | TDOCTeladoc HealthHealthcare | $5.89 | −3.28% | 80.7% | −7.4% | $1.07B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.